Periodic Reporting for period 1 - MGLycan (Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer)
Reporting period: 2019-06-01 to 2021-05-31
In this line, we propose:
A) Glycomimetics library able to bind tightly to the MGL to block cancer-DCs glycan mediated communication.
B) Build up a nanoparticles to take advantage of the multivalency to strength the binding.
Conclusions.
New synthetic approach to accelerate the glycomimetic obtaining has been developed.
New glycomimetic library has been synthesized.
In parallel, two computational works were carried out in collaboration with different groups from several Dutch Universities. In one of the projects, molecular dynamics (MD) simulations were applied to a Glycan-Lectin system to evaluate the binding of different glycans. In the second project, the MD simulations assisted in the identification of the molecular components required in the auxin analogs for their binding to TIR1.
Besides, the modification of N-glycans after natural product extraction is constrained to keep the asparagine, in order to use the amino group in the peptide backbone for further chemical modifications. However, both the conformation of the peptide bond and the length of the amino acid could have an effect on binding studies with target proteins. Another strategy relays in cleaving the peptide bond between the peptide and the glycan and perform a long chemical reaction to re-install the amino group in the anomeric position. In this regard, we have optimize the enzymatic peptide cleavage by controlling the reaction conditions without touching the native amino group on the anomeric position and we have installed a linker straightaway after peptide removal. This optimized methodology facilitates and reduce the time required in the modifications of natural products extracted glycans.